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caow@unc.eduAbstractWe have previously shown that insulin plays an important role in the nutrient-induced insulin
resistance. In this study, we tested the hypothesis that chronic exposure to excess long-acting
insulin (glargine) can cause typical type 2 diabetes mellitus (T2DM) in normal mice fed on a
chow diet. C57BL/6 mice were treated with glargine once a day for 8 weeks, followed by
evaluations offood intake, body weight, blood levels of glucose, insulin, lipids, and cytokines,
insulin signaling, histology of pancreas, ectopic fat accumulation, oxidative stress level, and
cholesterol content in mitochondria in tissues. Cholesterol content in mitochondria and its
association with oxidative stress in cultured hepatocytes and b-cells were also examined.
Results show that chronic exposure to glargine caused insulin resistance, hyperinsulinemia,
and relative insulin deficiency (T2DM). Treatment with excess glargine led to loss of
pancreatic islets, ectopic fat accumulation in liver, oxidative stress in liver and pancreas, and
increased cholesterol content in mitochondria of liver and pancreas. Prolonged exposure of
cultured primary hepatocytes and HIT-TI5 b-cells to insulin induced oxidative stress in a
cholesterol synthesis-dependent manner. Together, our results show that chronic exposure to







.0 UJournal of Endocrinology
(2014) 221, 469–480IntroductionType 2 diabetes mellitus (T2DM) has become a major
health and economic burden to industrialized societies. Its
negative impact on the general health and economy is still
rapidly increasing due to the continuing industrialization.It is very clear that the root of T2DM, in most cases, is the
excess calories due to overeating and/or lack of physical
activity. However, the exact mechanism by which excess
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221 :3 470T2DM is composed of three key components: insulin
resistance, hyperinsulinemia, and relative insulin insuffi-
ciency. Relative insulin insufficiency (overt T2DM) typi-
cally occurs over 10 years after insulin resistance and
hyperinsulinemia have been established (Kendall et al.
2009). In other words, insulin resistance/hyperinsuline-
mia is a precursor of T2DM. It is still highly debatable as to
how nutrients cause insulin resistance/hyperinsulinemia
and then T2DM. Inflammation, endoplasmic reticulum
stress, and mitochondrion-derived oxidative stress have
all been shown to be involved in the development of
insulin resistance/hyperinsulinemia (Hotamisligil 2010,
Samuel et al. 2010, Gregor & Hotamisligil 2011). The
presence of these multiple mechanisms itself demon-
strates that the primary mechanism of insulin resistance
has not been established. The primary cause or the original
root of insulin resistance and T2DM is ‘excess calories’,
which derive from three main dietary components:
glucose/carbohydrates, fat/fatty acids, and proteins/
amino acids. Thus, we have recently addressed several
simple questions. First, does glucose itself cause insulin
resistance in the absence of insulin? Our results show that
animals with untreated hyperglycemia in type 1 diabetes
mellitus (T1DM) respond to acute insulin challenge much
better than the diabetic animals treated with insulin,
suggesting that hyperglycemia itself does not cause insulin
resistance but treatment of T1DM with insulin does (Liu
et al. 2009a). In the absence of insulin, a high level of
glucose does not cause insulin resistance in cultured
hepatocytes either (Liu et al. 2009a). Secondly, does fat
itself cause insulin resistance without insulin? Our results
have shown that induction of insulin resistance by fats
from a high-fat diet (HFD) is prevented when insulin
secretion is disrupted with streptozotocin (Ning et al.
2011), suggesting that dietary fat itself does not cause
insulin resistance without insulin. In the absence of
insulin or when insulin signaling is blunted, free fatty
acids (FFA) do not cause insulin resistance in cultured
hepatocytes (Ning et al. 2011). Thirdly, does supple-
mentation of amino acids necessarily cause insulin
resistance? Results from others and us show that supple-
mentation of amino acids such as leucine to animals fed
on a HFD increases insulin sensitivity rather than causing
insulin resistance (Zhang et al. 2007, Guo et al. 2010,
Yang et al. 2013). Therefore, macronutrients themselves
do not cause insulin resistance without insulin. In other
words, insulin plays an essential role in converting
nutrients into insulin resistance and then T2DM.
We have previously shown that blunting insulin signaling
can actually prevent the HFD-induced insulinhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-14-0117
 2014 The authors
Printed in Great Britainresistance/hyperinsulinemia (Liu et al. 2009b). However,
it is still unknown whether continuous exposure to excess
exogenous insulin similar to that observed in subjects with
insulin resistance and hyperinsulinemia can cause T2DM
in normal mice fed on a chow diet. In this study, we
addressed this issue and found that chronic exposure to
excess insulin caused insulin resistance, hyperinsuline-
mia, and relative insulin deficiency, i.e., T2DM, in mice
fed on a chow diet.Materials and methods
Reagents and antibodies
Cholesterol, simvastatin, and DCF-DA were purchased
from Sigma. Antibodies against phosphorylated Akt or
total Akt, insulin receptor, serine636- or tyrosine612-
phosphorylated insulin receptor substrate 1 (IRS1) were
obtained from Cell Signaling Technologies, Inc. (Beverly,
MA, USA). Antibodies against b-actin, mouse immuno-
globulin G (IgG), and rabbit IgG were purchased from
Sigma. Amplex red cholesterol assay kit was purchased
from Invitrogen. The kit for measuring levels of gluta-
thione (GSH) and glutathione disulfide (GSSG) was
purchased from OxisResearch (Foster City, CA, USA).Animal experiments
C57BL/6 (B6) mice (male, 6–9-week old) from Charles
River were treated with either saline or a long- and slow-
acting insulin reagent, glargine (50 Unit/kg body weight,
s.c. injection, once a day), for 8 weeks. The dose of glargine
was determined according to our previous experiments
(Liu et al. 2009a) and transgenic expression of human
insulin gene (32 times of normal insulin level) in animals
determined by Marban et al. (1989). Mice were housed
individually at the regular room temperature, allowed to
feed on the regular chow diet (Prolab RMH 3000) ad
libitum, and kept at 12 h light:12 h darkness cycles. The
weekly measurements of blood glucose level were
performed after an 8 h fast with a glucose meter (Abbott
Diabetes Care, Inc.) with a little drop of tail blood. After an
8 h fast at the end of the 8-week experiment, mice were
sedated with pentobarbital (50 mg/kg body weight) and
killed by cervical dislocation, and mitochondria from
liver, gastrocnemius, and pancreas were isolated as
described previously. Mitochondrial cholesterol was
quantified. All animal studies were approved by the
Institutional Animal Care and Use Committee of The
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of Health.Culture of HIT-TI5 hamster pancreatic insulinoma cells
HIT-T15 hamster pancreatic insulinoma cells were pur-
chased from ATCC (Manasas, VA, USA) and cultured in
F12K medium containing 10% horse serum, 2.5% fetal
bovine serum (FBS), 100 U/ml penicillin, and 100 mg/ml
streptomycin at 37 8C in an atmosphere of 5% CO2. HIT-
T15 cells (2!104 cells/well) were seeded in a 96-well plate
and pre-incubated for 24 h before any experimentation.Measurements of serum cytokines, hormones, and lipids
Serum triglyceride (TG) and FFA were measured with kits
purchased from Cayman Chemical (Ann Arbor, MI, USA)
(Cat No: 10010303 and 700310). Leptin, adiponectin, and
tumor necrosis factor a (TNFa) were measured with kits
obtained from Abcam (Cambridge, UK) (Cat No:
ab100718, ab108785, and ab46105). Endogenous insulin
and growth hormone were detected with ELISA kits
purchased from Millipore (Billerica, MA, USA) (Cat No:
EZRMI-13K and EZRMGH-45K).Preparation and culture of primary hepatocytes
Mouse primary hepatocytes were isolated from male B6
mice (6–9 weeks) as we described previously (Cao et al.
2005, Xiong et al. 2006, Collins et al. 2007, Liu et al. 2009c).
Viable hepatocytes were suspended in Williams’ E medium
(Invitrogen) containing antibiotics (50 mg/ml penicillin,
50 mg/ml streptomycin, and 100 mg/ml neomycin). Cells
were seeded at a density of 3.5!105 cells per 100 mm Petri
dish (BD Falcon) pre-coated with 0.02% collagen type I.Measurement of peroxidized lipids
Levels of peroxidized lipids were indirectly determined
by measuring the levels of malondialdehyde (MDA), a
byproduct of lipid peroxidation with a commercialized kit
(Northwest Life Science Specialties, Vancouver, WA, USA)
as described previously (Aust et al. 1985). The level of MDA
was measured by quantifying the absorbance at 532 nm.Measurement of MnSOD activity
Manganese superoxide dismutase (MnSOD) activity was
determined using a commercially available kit (Cayman
Chemical Company) (Papazzo et al. 2011). Briefly,http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-14-0117
 2014 The authors
Printed in Great Britainxanthine oxidase and hypoxanthine were used to generate
superoxide radicals that were then detected by tetrazolium
salt and quantified at 540 nm with a microplate reader
(Cell Biolabs, USA). One unit of SOD was defined as the
amount of enzyme required to inhibit the dismutation of
the superoxide radical by 50%. Potassium cyanide (KCN,
1 mM)) was used to inhibit the Cu- and Zn-SOD.Histological examination of pancreas
Pancreatic slices (5 mm thickness) were fixed in 10%
neutral-buffered formalin/Bouin’s fluid overnight. All
the tissue samples were subjected to standard processing
and staining procedures. Paraffin-embedded sections of
5-micron were stained with hematoxylin and eosin, and
examined under a light microscope (Leitz Diaplan, USA).Measurement of GSH/GSSG
Levels of GSH and GSSG in tissue lysates were determined
with a kit purchased from OXIS International, Inc. (Foster
City, CA, USA) and normalized to protein levels. Measure-
ments of GSH and GSSG and calculation of the GSH:GSSG
ratio were performed in the following four steps:
i) determination of the reaction rate by time;
ii) construction of calibration curve; iii) calculation of
concentrations; and iv) calculation of the GSH:GSSG ratio
as GSH:GSSG ratioZ(GSHK2GSSG)/GSSG.RNA extraction and real-time PCR
Total RNAs were extracted from tissues with an RNeasy Mini
Kit (Qiagen)and reverse transcribed into cDNAs, which were
quantified by TaqMan Real-time PCR with specific probes
and primers and normalized to levels of m36B4.Preparation of mitochondria
To isolate mitochondria, tissue samples were collected
promptly. Mitochondria were isolated as described pre-
viously (Palmer et al. 1977). Tissues were then lysed with
1 ml ice-cold lysis buffer by pipetting up and down several
times, incubated for 10 min on ice on a shaker, and then
precipitated by centrifugation (at 1000 g, for 10 min).
Supernatants were removed and pellets were resuspended
in 1.5 ml MSE buffer containing 225 mM mannitol,
75 mM sucrose, 1 mM EGTA, 5 mM HEPES, pH 7.4, and
1 mg/ml BSA, followed by centrifugation at 1000 g for
3 min. Then supernatants were transferred to a clean
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Lipids in isolated mitochondria were extracted with
isopropanol. Free cholesterol was quantified using the
Amplex red cholesterol assay kit. Meanwhile, protein
levels in the same samples were measured with standard
Bio-Rad assays.
Immunoblotting
Proteins (30 mg) were denatured at 95 8C for 5 min in
a loading buffer (60 mM Tris, 2.5% SDS, 10% glycerol,
5% mercaptoethanol, and 0.01% bromophenol blue) and
subjected to 10% SDS–PAGE. Proteins in gels were trans-
ferred onto PVDF membranes and blocked with TBS
containing 0.05% Tween 20 (TBS-T) and 5% non-fat milk
for 1 h. After being washed with TBS-T, membranes were
probed with specific first antibodies against target proteins
(rabbit) or b-actin (mouse) (1:1000) overnight at 4 8C.
Membranes were then washed with TBS-T and incubated
with polyclonal secondary antibodies (1:5000) for 1 h at
room temperature. After three washes with TBS-T, mem-
branes were treated with ECF substrates (GE Healthcare,
Pittsburgh, PA, USA). Fluorescent bands were visualized and
then quantified by densitometry analysis using the Image-
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Time (week)Measurement of ROS production from cultured cells
Intracellular reactive oxygen species (ROS) was detected
using fluorescent DCF-DA as described previously (Palmer
et al. 1977, D’Alessandro et al. 2011). In brief, the
non-fluorescent dye freely permeates into cells, where it is
de-esterified to form ionized free acid (dichlorofluorescein)
and reacts with ROS to form fluorescent 20,70-dichlorofluo-
rescein (DCF). Cells were washed thrice with PBS and then
loaded with 20 mM H2DCF-DA for 30 min at 37 8C. The
fluorescence of DCF was analyzed using a plate reader
(SpectramaxGeminiEM,MolecularDevices) at theexcitation
and emission wavelengths of 490 and 530 nm respectively.Figure 1
Chronic exposure to excess insulin (glargine) increases the ratio of white fat
to body weight without obviously altering food intake and body weight.
C57CL/6 (B6) mice were treated with either glargine or saline daily for
8 weeks. Food intake (A) and body weight (B) were measured weekly.
Epididymis fat tissue was collected at the end of the experiment. (C) The
ratio of epididymis fat to body weight was calculated. Results represent
meanGS.D. of six to eight mice/group. **P!0.01 vs control.Statistical analysis
Data are presented as meanGS.D./S.E.M. Data were
compared by Student’s t-test with GraphPad Prism version
4.0 for Windows (San Diego, CA, USA). Differences at
values of P!0.05 were considered significant.http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-14-0117
 2014 The authors
Printed in Great BritainResults
Chronic exposure to excess insulin increases
white fat:body weight ratio
During the 8-week treatment with glargine, food intake and
body weight were measured weekly. As shown in Fig. 1A,Published by Bioscientifica Ltd
Table 1 Serum levels of cytokines, hormones, and lipids.
Results represent meanGS.D. of six to eight mice
Control Glargine
Leptin (ng/ml) 0.69G0.05 0.70G0.09
Adiponectin (mg/ml) 6.15G1.25 6.17G1.54
TNFa (ng/ml) 0.12G0.06 0.13G0.05
Growth hormone (ng/ml) 20.63G7.45 14.94G9.85
Triglyceride (mmol/l) 0.61G0.10 0.65G0.14
Free fatty acids (mmol/l) 0.48G0.12 0.44G0.07
Total cholesterol (mg/ml) 34.38G9.76 44.25G13.82*
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221 :3 473mice treated with glargine consumed slightly more diet at
the first week and then tended to consume slightly less diet
when compared with control mice although the changes
did not reach a statistical significance. Mice treated with
glargine gained slightly more body weight than control
mice although the gain reached a statistical significance
only on week 7 (Fig. 1B). However, the percentage of
epididymal fat (white adipose tissue, WAT) over the whole-
body weight was significantly increased in mice treated
with glargine. Treatment with glargine did not alter plasma
levels of leptin, adiponectin, TNFa, TG, and FFA but
increased plasma level of cholesterol (Table 1). These results
together demonstrate that chronic exposure to glargine
increases WAT and blood cholesterol level.C
Week 8
Control Glargine Control
Acute regular insulinNo regular insulin
*
Glargine



























Chronic exposure toexcess insulin (glargine) induces T2DM in normal mice fed
on a chow diet. After an 8 h fast, blood glucose (A and B) and serum insulin
(C) ofmice described in Fig.1 were measured. Someanimals were treated with
regular human insulin for 15 min (0.75 Unit/kg body weight, i.p.) after an 8 h
fast, followed by measurement of serum insulin. Results represent meanGS.D.
of six to eight animals/group. *P!0.05 vs control. **P!0.01 vs control.Chronic exposure to excess insulin induces T2DM in
normal mice fed on a chow diet
Fasting blood glucose levels were measured weekly during
the experiment. Signs of hypoglycemia such as poor
grooming and shivering were closely monitored, particu-
larly during the first 2 days of the glargine treatment. No
sign of hypoglycemia was ever noted. As shown in Fig. 2A
and B, fasting blood glucose level in mice treated with
glargine started to increase on week 1 and significantly
increased (150 mg/dl) on week 8. Fasting level of plasma
endogenous insulin measured was significantly increased
by glargine treatment (Fig. 2C). It should be noted that the
antibodies against insulin used in the ELISAs, in this study,
recognized only the regular insulin but not glargine. Hence,
the insulin detected here was endogenous or regular insulin.
Furthermore, administration of regular insulin during the
insulin tolerance increased the blood level of regular insulin
equally in mice with or without glargine treatment (Fig. 2C).
The increase in levels of both fasting blood glucose and
endogenous insulin established the notion that chronic
exposure to excess insulin induced insulin resistance inhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-14-0117
 2014 The authors
Printed in Great Britainanimals treated with glargine. These results together
demonstrate that chronic exposure to excess insulin/
glargine induced T2DM characterized by insulin resistance,
hyperinsulinemia, and relative insulin insufficiency.Chronic exposure to excess insulin induces insulin
resistance mainly in liver
To determine the effect of chronic exposure to excess insulin
on insulin sensitivity, levels of insulin receptor, serine and











































Chronic exposure to insulin (glargine) induces tissue-specific insulin
resistance in normal mice fed on a chow diet. After an 8 h fast, some mice
described in Fig. 1 as noted were treated with regular human insulin
(0.75 Unit/kg body weight, i.p.) for 15 min, followed by measuring levels of
insulin receptor, IRS1 serine phosphorylation, IRS1 tyrosine phosphoryl-
ation, Akt phosphorylation, total Akt, and b-actin using the immuno-
blotting technique with specific antibodies. Akt phosphorylation was
quantified and presented as meanGS.D. of three animals. *P!0.05 vs no
acute insulin treatment in control. DP!0.05 vs no acute insulin treatment in
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determined using the immunoblotting technique. As
shown in Fig. 3A, levels of insulin receptor and tyrosine
phosphorylation of IRS1 were not altered obviously by
glargine treatment in both liver and gastrocnemius. IRS1
serine phosphorylation was increased in both liver and
gastrocnemius, but much more dramatically in liver, by
glargine. Acute insulin challenge for 15 min did not alter
serine and tyrosine phosphorylations of IRS1 in liver or
gastrocnemius obviously. However, acute insulin challenge
elevated Akt phosphorylation in both liver and gastrocne-
mius in control mice (Fig. 3A and B). Treatment with
glargine increased the basal level of Akt phosphorylation in
both liver and gastrocnemius. Acute challenge with insulin
stimulated Akt phosphorylation in gastrocnemius but not
in liver of mice treated with glargine (Fig. 3A and B). These
results together show that chronic exposure to excess
insulin/glargine induced insulin resistance mainly in liver.http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-14-0117
 2014 The authors
Printed in Great BritainChronic exposure to excess insulin (glargine) appears to
decrease the number and size of pancreatic islets
To determine the effect of chronic exposure to excess
insulin (glargine) on pancreatic b-cells, pancreatic islets
were examined by histological evaluation. As shown in
Fig. 4, both the number and the size of pancreatic islets
were dramatically decreased by the treatment with
glargine. These results show that chronic exposure to
excess insulin appears to reduce pancreatic islet mass.Chronic exposure to excess insulin induces ectopic fat
accumulation in liver
As ectopic fat accumulation is known to be associated
with insulin resistance as reviewed previously (Cao et al.
2011), TG level was determined in liver and gastrocne-
mius. As shown in Fig. 5, TG content was significantly
enhanced by glargine in liver but not in gastrocnemius.
Similarly, treatment with glargine increased the
expression of the key lipogenic gene, fatty acid
synthase (Fas), obviously in liver but not in gastrocnemius
(Table 2). The effect of glargine on the expression of genes
involved in fat oxidation appeared to be different between
liver and gastrocnemius. Specifically, expression of the
long-chain acyl CoA dehydrogenase (Acadl) gene was
decreased by glargine in muscle but not in liver
(Table 2). These results together show that chronic
exposure to excess insulin (glargine) increases ectopic fat
accumulation in liver.Chronic exposure to excess insulin (glargine) induces
oxidative stress in liver and pancreas
It is known that oxidative stress plays a critical role in
induction of insulin resistance and tissue damage as
reviewed previously (Cao et al. 2011). Thus, oxidative
stress level was examined in liver, gastrocnemius, and
pancreas. As shown in Fig. 6A, the GSH:GSSG ratio was
decreased by treatment with glargine in liver but not in
gastrocnemius and pancreas. MnSOD activity was
dramatically increased in both liver and pancreas but not
in gastrocnemius (Fig. 6B). To investigate the mechanism
by which the mass of pancreatic islets was decreased by
glargine, the level of oxidized lipids was determined. As
shown in Fig. 6C, glargine treatment increased the level of
oxidized lipids (MDA) significantly in liver and pancreas,
but not in gastrocnemius. These results together show that
chronic exposure to excess insulin induces oxidative stress
in liver and pancreas.Published by Bioscientifica Ltd
× 10
Control Glargine




































Chronic exposure to excess insulin (glargine) leads to loss of pancreatic
islets in animals fed on a chow diet. Pancreas of mice described in Fig. 1
were collected from five mice per group, fixed, sectioned, stained with
hematoxylin and eosin, and visualized by microscopy (A). Typical views
were presented. The size and number of islets were quantified and
analyzed (B). Results represent meanGS.D. of six to eight mice per group.
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cholesterol content in mitochondria of liver and pancreas
To further investigate mechanisms of glargine-induced
insulin resistance and reduction of pancreatic mass, the
cholesterol content in mitochondria of liver, gastrocne-
mius, and pancreas was quantified. As shown in Fig. 7A,
treatment with glargine increased the cholesterol content
in mitochondria in liver and pancreas significantly but not
in gastrocnemius. The activity of the rate-limiting enzyme
of cholesterol synthesis, HMG-CoA reductase, was
increased by the treatment with glargine in both liver
and pancreas and unaltered in gastrocnemius (Fig. 7B).Prolonged exposure to insulin induces oxidative
stress in hepatocytes and b-cells
Tofurther investigate the effectof cholesterol onthe insulin-
induced oxidative stress, the effect of prolonged exposure to
insulin on ROS production and the GSH:GSSG ratio was
examined in cultured cells. As shown in Fig. 8A and B,
prolonged exposure to insulin increased the level of ROS in
bothhepatocytes andb-cells, andthe increasewasprevented
by inhibition of cholesterol synthesis with simvastatin.
These results together demonstrate that excess exposure to
insulin can induceoxidative stress inboth liver and pancreas
in a cholesterol synthesis-dependent manner.http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-14-0117
 2014 The authors
Printed in Great BritainDiscussion
The exact mechanism by which nutrients cause T2DM has
been intensively investigated but remains unestablished.
We have recently shown that insulin plays an essential
role in mediating the nutrient-induced insulin resistance,
a precursor of T2DM (Liu et al. 2009b, Cao et al. 2011, Ning
et al. 2011). In this study, we tested the hypothesis that
chronic exposure to excess insulin alone could cause
T2DM and made several novel findings.
First, chronic exposure to excess insulin (glargine)
caused insulin resistance, hyperinsulinemia, and relative
insulin insufficiency (Fig. 2). These are key features of
T2DM. It has long been known that administration of
excess amount of insulin to humans can cause hypergly-
cemia, which has been called the Somogyi phenomenon
(Somogyi 1959). It was considered that hypoglycemia
caused by the excess insulin leads to increased secretion
of gluconeogenic hormones such as growth hormone and
elevated gluconeogenesis (Somogyi 1960). However,
recent studies did not report any hypoglycemic condition
when the blood glucose level was monitored continuously
for 24 h in subjects with the Somogyi phenomenon
(Hoi-Hansen et al. 2005). During this study, we measured
the fasting blood glucose level weekly and did not observe
any hypoglycemic condition. The close monitoring of





















































Chronic exposure to excess insulin (glargine) leads to ectopic fat
accumulation in liver in mice fed on a chow diet. Triglyceride (TG) content
in the liver (A) and muscle (B) of mice described in Fig. 1 was examined as
detailed in ‘Materials and methods’. Results represent meanGS.D. of six to
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increase on week 1 of the treatment with glargine. We did
not observe any increase in plasma level of growth
hormone in this study (Table 1). Others did not find the
assumed changes in hormones (Gale et al. 1980). There-
fore, hyperglycemia caused by chronic exposure to excess
insulin is not likely to be due to hypoglycemia-induced
effects as suggested by Somogyi. Marban et al. (1989) haveTable 2 The mRNA levels of genes involved in lipogenesis and fa
G
Liver P valu
Cpt1a (Cpt1b) (Chpt1) 0.824G0.581 0.580
Acadm 1.542G1.118 0.328
Acadl 1.351G0.850 0.411
Srebp1 (Srebf1) 1.042G1.158 0.942
Srebp2 (Srebf2) 0.752G0.581 0.539
Fas 2.667G0.919† 0.007
Compared with control group, *P!0.05; †P!0.01.
http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-14-0117
 2014 The authors
Printed in Great Britainpreviously shown that hyperinsulinemia (32 times of
normal insulin level) induced by transgenic overexpres-
sion of the human insulin gene leads to a lean phenotype
in mice with severe insulin resistance and normal
glycemia. In this study, the fasting blood glucose level
started to increase at 1 week after the exposure to excess
insulin. The reason for the difference between this study
and Marban’s study is unclear but most likely to be due to
the types of insulin that were used. In Marban’s study, the
regular human insulin gene was overexpressed. Regular
insulin is fast acting and excess amount of it can induce
global insulin resistance instantly. Otherwise, the excess
regular insulin will cause lethal hypoglycemia. Severe
insulin resistance was exactly the same as observed in
those animals. In this study, the slow- and long-acting
insulin was used. Although the amount of glargine used in
this study was large, it did not cause overwhelming
hyperinsulinemia and severe global insulin resistance.
Instead, the chronic exposure to excess glargine caused
only moderate insulin resistance mainly in liver. We
believe that in comparison to the overwhelming global
insulin resistance induced by transgenic overexpression of
the regular insulin, hyperinsulinemia and the associated
insulin resistance induced by administration of glargine
mimic the hyperinsulinemia and insulin resistance
induced by nutrients better. Besides, the insulin in the
mice with transgenic overexpression of the insulin gene
comes from transgenic overexpression. Thus, those mice
will always produce enough insulin to overcome insulin
resistance and will not develop insulin deficiency
(relative), which is caused by the loss of pancreatic
b-cells and is a necessary component of T2DM. Similarly,
although insulinoma has been shown to be associated
with T2DM in subjects with morbid obesity (Wildbrett
et al. 1999), subjects with insulinoma mostly do not
develop typical T2DM because insulin is secreted in these
subjects from a tumor that will always produce enough
insulin to overcome insulin resistance. That is why,t oxidation. Results represent meanGS.D. of six to eight mice
largine vs control (fold)














































































































































Chronic exposure to excess insulin (glargine) leads to oxidative stress in liver
and pancreas in mice fed on a chow diet. GSH:GSSG ratio (A), MnSOD
activity (B), and malondialdehyde (MDA) (C) in liver, pancreas, and
gastrocnemius of mice described in Fig. 1 were measured and normalized
to protein levels of the same samples as detailed in ‘Materials and
methods’. Results represent meanGS.D. of six animals per group.
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Printed in Great Britainoverall, insulinoma is rarely linked to T2DM (Ishii et al.
1993, Kane et al. 1993, Lei et al. 2007).
Secondly, chronic exposure to excess amount of
slow- and long-acting insulin, glargine, induces moderate
and tissue-specific insulin resistance. There is no doubt
that exposure to excess insulin can cause global insulin
resistance through a feedback loop that includes tyrosine-
phosphorylated IRS1/2, PI3K, Akt, mTOR, S6K, and
serine-phosphorylated IRS1/2 (Accili 2004). However, the
insulin resistance observed in this study may not be so
simple. First, insulin resistance induced by excess insulin
observed in this study occurred mainly in liver as
evidenced by the increased level of serine-phosphorylated
IRS1 and lack of Akt phosphorylation in response to acute
insulin challenge in liver but not in muscle (Fig. 3).
Secondly, other key features of insulin resistance such as
ectopic fat accumulation and oxidative stress occurred
in liver but not in muscle (Figs 5 and 6). Thirdly, the
cholesterol content of mitochondria was increased in liver
but not in muscle (Fig. 7) and increased mitochondrial
cholesterol and cholesterol synthesis induced by the
prolonged exposure to insulin are associated with elevated
ROS production and oxidative stress in hepatocytes
(Fig. 8). Therefore, it appears that the insulin resistance
induced by glargine in this study is more likely caused by
the increased cholesterol content in mitochondria.
Thirdly, chronic exposure to excess insulin (glargine)
decreases the number and size of pancreatic islets. Overt
T2DM occurs only in some subjects when a certain
amount of pancreatic islets is lost after a long period of
insulin resistance and hyperinsulinemia (Accili 2004). The
mechanism that causes the loss of pancreatic b-cells in
T2DM patients remains unestablished, but it is generally
believed that it is associated with oxidative stress (Cao
et al. 2011). In this study, both the number and size of
pancreatic islets were dramatically decreased by the
chronic exposure to excess insulin (Fig. 4) although
animals were still producing four times more insulin
than control animals (Fig. 2), indicating that the reserve of
insulin secretion is normally very high and only a small
portion of it is normally utilized. Results from this study
show that chronic exposure to insulin induced oxidative
stress in pancreas (Fig. 6). The increased oxidative stress is
linked to elevated cholesterol content in mitochondria
(Fig. 7). In cultured b-cells, the increased production of
ROS and oxidative stress induced by the prolonged
exposure to insulin can be prevented by inhibition of
cholesterol synthesis (Fig. 8). Therefore, the loss of
pancreatic islets observed in this study was likely to be






































































































Chronic exposure to excess insulin (glargine) leads to increased cholesterol
content in mitochondria of liver and pancreas in mice fed on a chow diet.
Mitochondria were freshly isolated from liver, pancreas, and gastrocnemius
of the mice described in Fig. 1. Levels of mitochondrial cholesterol (A) and
HMG-CoA reductase (HMG-CoA-R) (B) in the noted tissues were measured as
detailed in ‘Materials and methods’. Results represent meanGS.D. of six













































Chronic exposure to excess insulin (glargine) leads to oxidative stress in
cultured hepatocytes and b-cells in a cholesterol synthesis-dependent
manner. Primary mouse hepatocytes (A) and HIT-T15 b-cells (B) were treated
with insulin (5 nM) in the presence or absence of simvastatin (10 mM) for
24 h, followed by the measurements of ROS as detailed in ‘Materials and
methods’. Results represent meanGS.E.M. of three independent experi-


















Research X YANG, S MEI and others Insulin induces type 2 diabetes
mellitus
221 :3 478implications in understanding as to why T2DM patients
gradually become insulin dependent after using insulin.
It is currently believed that they become more insulin
resistant and thus need more insulin to control their blood
glucose level after using insulin. However, based on our
findings in this study, it is quite possible that those
patients may be losing their pancreatic islets faster after
using insulin, particularly those who use a relatively large
amount of long-acting insulin reagents.
Our findings in this study have a great level of
importance because various insulin reagents including
long-acting insulin reagents are currently widely used inhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-14-0117
 2014 The authors
Printed in Great BritainT2DM patients. Theoretically, it is impossible to use
insulin properly if insulin reagents are only injected into
patients because insulin level goes up and down in a linear
fashion after an injection instead of the pulsatile fashion
normally occurring in humans. The loss of pulsatile
insulin secretion alone is known to cause insulin
resistance (Shanik et al. 2008). In other words, the
application of insulin reagents via injections as the general
practice in T2DM patients now is bound to aggravate
insulin resistance in T2DM and increases the usage of
insulin, leading to the chronic exposure to excess insulin.
The exposure to excess insulin can not only aggravate
insulin resistance and lead to loss of endogenous
pancreatic islets as observed in this study, but also lead
to many other severe consequences. For example, many
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secretion such as sulfonylureas is associated with increased
mortalities due to various cardiovascular disorders or
cancer (Eurich et al. 2007, Anselmino et al. 2008,
Currie et al. 2009, Baur et al. 2011, Buchs &
Silverman 2011, La Vecchia 2011, Lebovitz 2011, Nandish
et al. 2011, Sehra et al. 2011, Currie & Johnson 2012).
Therefore, the current practice in using insulin reagents in
T2DM patients requires more caution and more thorough
and long-term evaluations.Declaration of interest
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